3SBio Inc.
1530Biotechnology
HK$13.75+0.44%As of Oct 29vs prior close
- Market cap
- $4.3B
- P/E (TTM)
- 3.5×
- P/E (FY1)
- 11.5×
- From 52W high
- −59.42%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥17.9B
- Net margin
- 46.29%
- Dividend yield
- 1.82%
Nomior Score
40
Anchored CompounderBottom 30% of the scored universe
Growth42
Quality69
Value69
Momentum2
Resilience45
Growth
+37.11%revenue a year over 3 fiscal years
YE22 CN¥6.9BLTM CN¥17.9B
Connections
Revenue to profitYE25
48% of revenue became net profit, up 25 pts on a year.